|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 38/55 | (2006.01) |
| A61K 35/16 | (2015.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3071219 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14809567.2 |
| Date of filing the European patent application | 2014-11-21 | |
| (97) | Date of publication of the European application | 2016-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (86) | Number | PCT/US2014/066784 |
| Date | 2014-11-21 |
| (87) | Number | WO 2015/077543 |
| Date | 2015-05-28 |
| (30) | Number | Date | Country code |
| 201361907550 P | 2013-11-22 | US | |
| 201462029086 P | 2014-07-25 | US |
| (72) |
BROOM, Colin, US
UKNIS, Marc, E., US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnų sukelto atmetimo gydymo būdai organų transplantacijos pacientuose su C1 esterazės inhibitoriumi |
| METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-10-22 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-11-19 |